A Study of Nasopharyngeal Carcinoma From Guangdong

Last updated: June 13, 2017
Sponsor: Sun Yat-sen University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Nasopharyngeal Cancer

Treatment

N/A

Clinical Study ID

NCT03003182
2016-FXY-098-Dept. of RT
  • All Genders

Study Summary

This prospective cohort study aims to establish prognostic models, to discover toxicity associated predictors and to validate randomized trials in clinical practice.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • histological confirmed nasopharyngeal carcinoma;

  • scanned by magnetic resonance imaging from calvaria vertex to clavicles beforetreatment;

  • pretreatment Epstein-Barr virus deoxyribonucleic acid copy number is available;

  • irradiated with intensity-modulated radiotherapy;

Exclusion

Exclusion Criteria:

  • finishing anticancer therapy in two or more hospitals;

  • pregnancy or lactation;

  • diagnosed with other sort of cancer before or during the treatment.

Study Design

Total Participants: 2000
Study Start date:
May 10, 2017
Estimated Completion Date:
May 31, 2021

Connect with a study center

  • Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong 510060
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.